INTRODUCTION
Sansalvamide A (San A, 1) is a natural product isolated from a marine fungus (Fussarium ssp.) .
1
This cyclic depsipeptide exhibits a potent anticarcinogenic activity on multiple cancer cell lines.
1b
In continuing our research on the synthesis of peptoids with potential pharmacological activity, 2 we decided to perform the synthesis of cyclic depsipeptoids analogues of San A (2a-b, Figure 1 ) based on a strategy previously developed in our group, 2a by combination of Ugi and Passerini reactions. To the best of our knowledge, the synthesis of cyclic depsipeptoids has not yet been explored. 
RESULTS AND DISCUSSION
The aim of our study was to develop a general strategy for the synthesis of cyclic pentadepsipeptoids, as shown in Scheme 1. This strategy is based on: (a) formation of a peptoid via Ugi reaction; (b) ester hydrolysis; (c) formation of an acyclic tetradepsipeptoid scaffold in the Passerini reaction; (d) deprotection of the amine/acid and (e) a macrocyclization step via Ugi reaction. Peptoid 7 was prepared in 81% yield by an Ugi 4-component reaction (U-4CR) using benzylamine 3, paraformaldehyde 4, N-Boc-glycine 5 and methyl isocyanoacetate 6 (Scheme 1) using microwave (MW) irradiation for 3 min (45 °C, 150 W). Peptoid 7 was hydrolyzed after basic treatment (LiOH, THF/H 2 O) to give the corresponding acid in quantitative yield. Acid 8 was employed in a Passerini reaction with isobutyraldehyde 9 and tertbutyl isocyanoacetate 10, under µW irradiation for 4 min (60 °C, 40 W) affording the acyclic tetradepsipeptoid 11 in 61% yield. Removal of the Boc protecting group and ester hydrolysis were achieved after treatment of compound 11 with TFA in CH 2 Cl 2 giving the amino acid in quantitative yield. Subsequent macrocyclization reactions involving Ugi threecomponent four-center reaction (U-3C4CR) using the obtained amino acid with paraformaldehyde and isopropyl/isobutyl isocyanide to give the target cyclic pentadepsipeptoid are in progress in our laboratory.
CONCLUSION
A fast and general synthetic route was developed for the synthesis of cyclic pentadepsipeptoids via consecutive multicomponent reactions. 
